These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 33854963)

  • 1. Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy.
    Wang S; Feng W; Wang W; Ye X; Chen H; Yu C
    Front Oncol; 2021; 11():618764. PubMed ID: 33854963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of PI3K/Akt Pathway Inhibition and Plk1 Depletion Can Enhance Chemosensitivity to Gemcitabine in Pancreatic Carcinoma.
    Mao Y; Xi L; Li Q; Wang S; Cai Z; Zhang X; Yu C
    Transl Oncol; 2018 Aug; 11(4):852-863. PubMed ID: 29753186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine-resistant human pancreatic cancer cells.
    Lin JH; Chen SY; Lu CC; Lin JA; Yen GC
    Phytother Res; 2020 Aug; 34(8):2053-2066. PubMed ID: 32185829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide inhibits Skp2 expression to increase chemosensitivity to gemcitabine in pancreatic cancer cells.
    Gao J; Wang G; Wu J; Zuo Y; Zhang J; Chen J
    Am J Transl Res; 2019; 11(2):991-997. PubMed ID: 30899398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LW6 enhances chemosensitivity to gemcitabine and inhibits autophagic flux in pancreatic cancer.
    Zhang X; Kumstel S; Jiang K; Meng S; Gong P; Vollmar B; Zechner D
    J Adv Res; 2019 Nov; 20():9-21. PubMed ID: 31193017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of gemcitabine resistance-related AHNAK2 gene associated with prognosis and immune infiltration in pancreatic cancer.
    Ou G; Tian Z; Su M; Yu M; Gong J; Chen Y
    Heliyon; 2024 Jul; 10(13):e33687. PubMed ID: 39040243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing chemosensitivity of PANC1 pancreatic cancer cells to gemcitabine using ANGTPL4, Notch1 and NF-κβ1 siRNAs.
    Al-Kadash A; Alshaer W; Mahmoud IS; Wehaibi S; Zihlif M
    Future Sci OA; 2024; 10(1):FSO918. PubMed ID: 38817387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BUB1 Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Inhibiting Ferroptosis.
    Wang W; Zhou X; Kong L; Pan Z; Chen G
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL5 knockdown attenuated gemcitabine resistance of pancreatic cancer through regulation of cancer cells and tumour stroma.
    Lee NH; Ma Y; Ang CS; Dumesny C; Huynh N; Yang Y; Wang K; Nikfarjam M; He H
    Am J Transl Res; 2023; 15(4):2676-2689. PubMed ID: 37193135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells
    Yang X; Wang W; Zhang X; Zou Q; Cai L; Yu B
    Exp Ther Med; 2019 Mar; 17(3):1697-1705. PubMed ID: 30783438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-137 inhibits autophagy and chemosensitizes pancreatic cancer cells by targeting ATG5.
    Wang ZC; Huang FZ; Xu HB; Sun JC; Wang CF
    Int J Biochem Cell Biol; 2019 Jun; 111():63-71. PubMed ID: 30710750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCA8-mediated efflux of taurocholic acid contributes to gemcitabine insensitivity in human pancreatic cancer via the S1PR2-ERK pathway.
    Yang C; Yuan H; Gu J; Xu D; Wang M; Qiao J; Yang X; Zhang J; Yao M; Gu J; Tu H; Gan Y
    Cell Death Discov; 2021 Jan; 7(1):6. PubMed ID: 33431858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal ACADM sensitizes gemcitabine-resistance through modulating fatty acid metabolism and ferroptosis in pancreatic cancer.
    Yang Y; Gu H; Zhang K; Guo Z; Wang X; Wei Q; Weng L; Han X; Lv Y; Cao M; Cao P; Huang C; Qiu Z
    BMC Cancer; 2023 Aug; 23(1):789. PubMed ID: 37612627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.
    Xiong J; Wang D; Wei A; Ke N; Wang Y; Tang J; He S; Hu W; Liu X
    Oncotarget; 2017 Dec; 8(64):107500-107512. PubMed ID: 29296182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative acetylome and phosphorylome analysis reveals Girdin affects pancreatic cancer progression through regulating Cortactin.
    Yang L; Fu Q; Miao L; Ding Q; Li X; Wang J; Jiang G; Wang Y
    Aging (Albany NY); 2020 May; 12(9):7679-7693. PubMed ID: 32369440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPK-related kinase 5 (ARK5) enhances gemcitabine resistance in pancreatic carcinoma by inducing epithelial-mesenchymal transition.
    Wang X; Song Z; Chen F; Yang X; Wu B; Xie S; Zheng X; Cai Y; Chen W; Zhong Z
    Am J Transl Res; 2018; 10(12):4095-4106. PubMed ID: 30662653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TYRO3 promotes chemoresistance via increased LC3 expression in pancreatic cancer.
    Hara K; Horikoshi Y; Morimoto M; Nakaso K; Sunaguchi T; Kurashiki T; Nakayama Y; Hanaki T; Yamamoto M; Sakamoto T; Fujiwara Y; Matsura T
    Transl Oncol; 2023 Feb; 28():101608. PubMed ID: 36577166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma.
    Zhou L; Jia S; Ding G; Zhang M; Yu W; Wu Z; Cao L
    J Cancer; 2019; 10(21):5031-5040. PubMed ID: 31602254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Girdin regulates the proliferation and apoptosis of pancreatic cancer cells via the PI3K/Akt signalling pathway.
    Wang S; Lei Y; Cai Z; Ye X; Li L; Luo X; Yu C
    Oncol Rep; 2018 Aug; 40(2):599-608. PubMed ID: 29901184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling.
    Wang B; Shen C; Li Y; Zhang T; Huang H; Ren J; Hu Z; Xu J; Xu B
    Onco Targets Ther; 2019; 12():5751-5765. PubMed ID: 31410021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.